Skip to main content

Your CDMO specialized in ex-vivo and in-vivo lentiviral vectors

Making the medicine of the future a reality

With expertise in virology, we tailor solutions to meet specific requirements of your lentiviral vector for both ex-vivo and in-vivo administration.

Business model

GMP CDMO focused on different stages of the process.

Specialization

We work exclusively in lentivirus, offering comprehensive services.

Customized service

Technical adaptation and timely slot availability for each project.

Quality and regulatory

Compliance with EMA and FDA regulatory requirements.
Trusted by industry leaders

Vivebiotech in data
  • +50 clients

    in the US, Europe, Asia and Australia
  • 10 years

     of lentiviral vectors experience

  • + 180 batches manufactured in bioreactor

    + 60 batches in reactor per year

    + 10 in-vivo programs

    In 7 dedicated cleanrooms

  • + 140 people

    combining young talent and experience
Our clients locations

                                                                                                                                                                                                                                                                                                                                                                Our clients locations

About us

We are a Contract Development and Manufacturing Organization (CDMO) with over 50 biotech and pharmaceutical companies worldwide that have placed their trust in us.

Our value

VIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.
Our Collaborators and Recognitions